GO:0044281 small molecule metabolic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0044281 (small molecule metabolic process) describes the set of biological processes that transform small molecules, which are low-molecular-weight organic compounds that serve as substrates, products, cofactors, and signaling molecules.
• Small molecule metabolism is central to energy production, biosynthesis, detoxification, and cell signaling, and its dysregulation is linked to cancer, neurodegeneration, and metabolic disorders.
• Key genes include enzymes such as GAPDH, PKM, LDHA, and IDH1, as well as transporters and regulatory proteins that control flux through metabolic pathways.
• Small molecules can modulate protein function and homeostasis, making them valuable tools for probing metabolic processes and for therapeutic development.
• Advanced methods such as high-throughput screening, organ-on-a-chip, and drug affinity responsive target stability (DARTS) enable the study of small molecule metabolism and its regulation.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential for dissecting the causal roles of metabolic genes in health and disease.
Description
Small molecule metabolic process (GO:0044281) encompasses the chemical reactions and pathways involving small molecules, which are low-molecular-weight organic compounds typically below 900 Da. These molecules include metabolites such as sugars, amino acids, lipids, nucleotides, and their derivatives, which are interconverted through enzymatic reactions to sustain life. The term is a broad biological process category that covers anabolic and catabolic pathways, as well as the transport and regulation of small molecule levels within cells. Understanding this process is fundamental to biochemistry, pharmacology, and medicine because small molecules serve as energy sources, building blocks, signaling messengers, and cofactors. Research into small molecule metabolic process has been accelerated by advances in high-throughput screening, which allows the rapid identification of small molecules that modulate metabolic pathways. Small molecules are also valuable tools for probing protein function and homeostasis, as they can act as inhibitors, activators, or degraders of specific proteins. The study of small molecule metabolism is therefore not only about understanding basic biology but also about developing new therapeutic strategies for diseases such as cancer, neurodegeneration, and metabolic disorders. In the post-genomic era, the integration of CRISPR-based gene editing with small molecule research has opened new avenues for dissecting metabolic pathways. By knocking out, mutating, or overexpressing genes involved in small molecule metabolism, researchers can determine their causal roles in cellular processes and disease. This article provides a comprehensive overview of GO:0044281, covering its definition, key genes, regulatory mechanisms, disease associations, and the experimental models and methods used to study it.
small molecule metabolic process At A Glance
| GO ID | GO:0044281 |
|---|---|
| GO term | small molecule metabolic process |
| Ontology | biological_process |
| Synonym | none |
| Major function | Encompasses the chemical reactions and pathways involving small molecules, including their synthesis, breakdown, and interconversion. |
| Related terms | Small molecule biosynthetic process (GO:0044283), small molecule catabolic process (GO:0044282) |
| Found in | All living organisms, from bacteria to humans |
| Substrates | Sugars, amino acids, lipids, nucleotides, vitamins, and other low-molecular-weight compounds |
What Is GO:0044281?
GO:0044281, small molecule metabolic process, is a biological process term that describes the chemical reactions and pathways involving small molecules, which are low-molecular-weight organic compounds. This includes the synthesis (anabolism), breakdown (catabolism), and interconversion of small molecules, as well as the regulation of their concentrations within cells. The term is broad and encompasses many specific metabolic pathways, such as glycolysis, the citric acid cycle, amino acid metabolism, and lipid metabolism. It does not include the metabolism of macromolecules like proteins or nucleic acids, which are covered by separate GO terms.
Why Is small molecule metabolic process Important in Cell Biology?
Small molecule metabolic process is fundamental to all aspects of cellular life, providing energy, building blocks, and signaling molecules necessary for growth, reproduction, and homeostasis. Dysregulation of small molecule metabolism is a hallmark of many human diseases, including cancer, diabetes, neurodegeneration, and infectious diseases. Moreover, small molecules are the primary focus of drug discovery, as many therapeutics are small molecules that modulate metabolic enzymes or pathways. Therefore, understanding the mechanisms, regulation, and disease relevance of small molecule metabolic process is critical for basic research and translational medicine.
• Provides energy and biosynthetic precursors for cell growth and proliferation.
• Regulates cellular signaling and homeostasis through metabolites and cofactors.
• Dysregulation is linked to cancer, neurodegeneration, and metabolic disorders.
• Small molecules are key tools in drug discovery and chemical biology.
• Enables the development of high-throughput screening assays for metabolic targets.
• Involved in host-pathogen interactions and immune responses.
• Essential for understanding drug metabolism and pharmacokinetics.
• Facilitates the study of enzyme mechanisms and protein-small molecule interactions.
• Supports the development of organ-on-a-chip models for metabolic studies.
• Provides a basis for CRISPR-based functional genomics of metabolic genes.
What Happens During small molecule metabolic process?
Substrate uptake and activation
In simple terms: Cells take in small molecules and prepare them for chemical reactions.
Small molecule metabolic processes begin with the uptake of substrates from the environment or their release from intracellular stores. Transporters and channels facilitate the movement of small molecules across membranes. Once inside the cell, substrates may be activated by phosphorylation, adenylation, or other modifications to become reactive intermediates. For example, glucose is phosphorylated to glucose-6-phosphate by hexokinase, trapping it in the cell and priming it for glycolysis. These initial steps are often regulated by signaling pathways that sense nutrient availability.
Enzymatic conversion and pathway flux
In simple terms: Enzymes convert one small molecule into another through a series of steps.
The core of small molecule metabolism consists of enzymatic reactions that convert substrates into products. These reactions are organized into pathways, such as glycolysis, the citric acid cycle, and amino acid biosynthesis. Enzymes catalyze these conversions with high specificity, often using cofactors like NAD+, FAD, or coenzyme A. The flux through these pathways is regulated by allosteric effectors, post-translational modifications, and gene expression. Small molecule tunnels in metalloenzymes can facilitate the channeling of substrates and products, enhancing catalytic efficiency.
Regulation and feedback control
In simple terms: Cells adjust metabolic pathways to meet their needs.
Small molecule metabolic processes are tightly regulated to maintain homeostasis. Feedback inhibition, where the end product of a pathway inhibits an upstream enzyme, is a common mechanism. Hormones and growth factors can also regulate metabolic flux through signaling cascades, such as the mTOR pathway, which promotes anabolism when nutrients are abundant. Additionally, small molecules can modulate protein homeostasis by acting as molecular glues or degraders, thereby influencing metabolic enzyme levels.
Product utilization and excretion
In simple terms: The final products are used by the cell or removed as waste.
The products of small molecule metabolism are either utilized for biosynthesis, energy production, or signaling, or they are excreted as waste. For instance, ATP generated from glucose oxidation powers cellular processes, while urea is excreted to remove excess nitrogen. Some metabolites, such as lactate, can be secreted and used by other cells or tissues. The balance between utilization and excretion is critical for preventing toxic accumulation and maintaining metabolic health.
Key Genes Involved in GO:0044281 small molecule metabolic process
The following genes encode enzymes, transporters, and regulatory proteins that are central to small molecule metabolic processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GAPDH | Catalyzes the sixth step of glycolysis, converting glyceraldehyde-3-phosphate to 1,3-bisphosphoglycerate | Commonly used as a loading control in Western blots; also has non-glycolytic roles in apoptosis and DNA repair |
| PKM | Pyruvate kinase, catalyzes the final step of glycolysis, producing pyruvate and ATP | Isoform switching (PKM1/PKM2) is linked to cancer metabolism and Warburg effect |
| LDHA | Lactate dehydrogenase A, converts pyruvate to lactate under anaerobic conditions | Target for cancer therapy; involved in metabolic reprogramming |
| IDH1 | Isocitrate dehydrogenase 1, catalyzes oxidative decarboxylation of isocitrate to alpha-ketoglutarate | Mutations in IDH1 are found in gliomas and leukemias, leading to oncometabolite 2-HG production |
| IDH2 | Isocitrate dehydrogenase 2, mitochondrial isoform | Mutations in IDH2 also produce 2-HG and are implicated in cancer |
| SDHA | Succinate dehydrogenase complex flavoprotein subunit A, part of both TCA cycle and electron transport chain | Mutations cause hereditary paraganglioma and pheochromocytoma |
| FH | Fumarate hydratase, catalyzes conversion of fumarate to malate in TCA cycle | Mutations lead to hereditary leiomyomatosis and renal cell cancer |
| HK2 | Hexokinase 2, phosphorylates glucose to glucose-6-phosphate | Overexpressed in many cancers; target for metabolic inhibitors |
| PFKM | Phosphofructokinase, muscle type, rate-limiting enzyme of glycolysis | Mutations cause Tarui disease (glycogen storage disease type VII) |
| ALDOA | Aldolase A, fructose-bisphosphate aldolase, catalyzes cleavage of fructose-1,6-bisphosphate | Involved in glycolysis and gluconeogenesis; potential cancer target |
| ENO1 | Enolase 1, catalyzes conversion of 2-phosphoglycerate to phosphoenolpyruvate | Multifunctional protein; plays roles in glycolysis and tumor progression |
| TPI1 | Triosephosphate isomerase 1, interconverts dihydroxyacetone phosphate and glyceraldehyde-3-phosphate | Deficiency causes triosephosphate isomerase deficiency, a glycolytic enzymopathy |
| PGK1 | Phosphoglycerate kinase 1, generates ATP in glycolysis | Also has roles in DNA repair and angiogenesis |
| PGAM1 | Phosphoglycerate mutase 1, catalyzes conversion of 3-phosphoglycerate to 2-phosphoglycerate | Overexpressed in cancers; potential therapeutic target |
| G6PD | Glucose-6-phosphate dehydrogenase, rate-limiting enzyme of pentose phosphate pathway | Deficiency causes hemolytic anemia; involved in NADPH production and redox balance |
| ACLY | ATP citrate lyase, converts citrate to acetyl-CoA for fatty acid synthesis | Target for cancer and metabolic disorders |
| FASN | Fatty acid synthase, catalyzes de novo synthesis of fatty acids | Overexpressed in many cancers; target for inhibitors |
| CPT1A | Carnitine palmitoyltransferase 1A, rate-limiting enzyme for mitochondrial fatty acid oxidation | Regulates energy homeostasis; target for diabetes and obesity |
How Is small molecule metabolic process Regulated?
Small molecule metabolic process is regulated at multiple levels. Allosteric regulation allows immediate feedback in response to metabolite levels, such as ATP inhibiting phosphofructokinase. Hormonal signals, including insulin and glucagon, control metabolic flux through phosphorylation cascades. Transcriptional regulation by nuclear receptors and transcription factors such as SREBP and ChREBP adjusts enzyme expression in response to nutrient availability. Additionally, small molecules can directly modulate protein homeostasis by acting as degraders or stabilizers, thereby influencing metabolic enzyme levels. The mTOR pathway integrates growth factor and nutrient signals to promote anabolic processes, including protein and lipid synthesis.
small molecule metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IDH1 | Glioma, acute myeloid leukemia; production of oncometabolite 2-HG | Knock-in of IDH1 R132H mutation in cell lines; xenograft models |
| SDHA | Hereditary paraganglioma and pheochromocytoma | Knockout of SDHA in cell lines; assessment of succinate accumulation |
| FH | Hereditary leiomyomatosis and renal cell cancer | Knockout of FH in renal cells; measurement of fumarate levels |
| TPI1 | Triosephosphate isomerase deficiency; hemolytic anemia | Point mutation knock-in of TPI1 E104D in hematopoietic cells |
| G6PD | Glucose-6-phosphate dehydrogenase deficiency; hemolytic anemia | Knockout of G6PD in erythroid cells; oxidative stress assays |
Cancer metabolism
Cancer cells often reprogram small molecule metabolism to support rapid proliferation, a phenomenon known as the Warburg effect. This includes increased glycolysis, glutaminolysis, and fatty acid synthesis. Mutations in metabolic enzymes such as IDH1, IDH2, SDHA, and FH lead to the accumulation of oncometabolites like 2-hydroxyglutarate, succinate, and fumarate, which can inhibit alpha-ketoglutarate-dependent dioxygenases and promote tumorigenesis. Targeting metabolic pathways is a promising therapeutic strategy, and small molecule inhibitors of glycolytic enzymes are under development.
Neurodegenerative diseases
Altered small molecule metabolism is increasingly recognized in neurodegenerative diseases such as Alzheimer's disease. For example, intranasal delivery of nanodrug-loaded liposomes has been shown to regulate microglial polarization and improve cognitive function in Alzheimer's models, highlighting the role of small molecules in neuroinflammation. Metabolic dysfunction, including impaired glucose metabolism and mitochondrial dysfunction, contributes to neuronal death. Small molecule modulators of protein homeostasis are being explored as therapeutic agents for neurodegeneration.
Metabolic disorders
Inherited mutations in metabolic enzymes cause a variety of metabolic disorders, such as triosephosphate isomerase deficiency (TPI1), Tarui disease (PFKM), and glucose-6-phosphate dehydrogenase deficiency (G6PD). These conditions often present with hemolytic anemia, muscle weakness, and exercise intolerance. Additionally, acquired metabolic disorders like type 2 diabetes and obesity involve dysregulation of small molecule metabolism, including impaired insulin signaling and lipid handling. Small molecule drugs targeting metabolic pathways are mainstays of treatment for these disorders.
From small molecule metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a metabolic gene affect cell proliferation? | CRISPR knockout in cancer cell lines followed by growth assays |
| Does a specific point mutation alter enzyme activity? | CRISPR point mutation knock-in (e.g., IDH1 R132H) and biochemical assays |
| Does overexpression of a metabolic gene promote tumor growth? | CRISPR overexpression (e.g., via CRISPRa) in xenograft models |
| How does a metabolic gene affect metabolite levels? | Knockout or knock-in followed by metabolomics profiling |
| Can a small molecule inhibitor target a metabolic enzyme? | Drug affinity responsive target stability (DARTS) and cellular assays |
| Does a metabolic gene regulate immune cell function? | CRISPR knockout in primary immune cells and functional assays |
How to Study the small molecule metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| High-throughput screening | Effect of compounds on metabolic readouts | Drug discovery for metabolic enzymes |
| DARTS | Protein targets of small molecules | Target identification for small molecule probes |
| Organ-on-a-chip | Physiological responses to small molecules | Drug transport and toxicity studies |
| Metabolomics | Levels of small molecule metabolites | Metabolic profiling in disease models |
| Flux analysis | Rate of metabolic pathway flux | Quantifying metabolic reprogramming |
| CRISPR knockout | Loss-of-function effects on metabolism | Functional genomics of metabolic genes |
| CRISPR knock-in | Effect of specific mutations on metabolism | Modeling disease-associated mutations |
| Small-molecule degraders | Induced degradation of target proteins | Modulating protein homeostasis |
High-throughput screening
High-throughput screening (HTS) is a powerful method to identify small molecules that modulate metabolic pathways. It involves testing thousands of compounds for their ability to affect a specific metabolic readout, such as enzyme activity or cell viability. HTS can be used to discover inhibitors or activators of metabolic enzymes, which can serve as chemical probes or drug leads. Advances in automation and miniaturization have made HTS more efficient and cost-effective.
Drug affinity responsive target stability (DARTS)
DARTS is a method for identifying the protein targets of small molecules. It relies on the principle that binding of a small molecule to its target protein can protect the protein from proteolysis. By comparing proteolytic patterns in the presence and absence of the small molecule, researchers can identify specific targets. DARTS has been used to uncover the mechanisms of action of various small molecules, including those involved in metabolic regulation.
Organ-on-a-chip models
Organ-on-a-chip models, such as blood-brain barrier (BBB) chips, are microfluidic devices that mimic the structure and function of human organs. These models allow the study of small molecule transport, metabolism, and toxicity in a physiologically relevant context. For example, BBB-on-a-chip can be used to assess drug delivery to the brain and to study neuroinflammatory processes. Such models are valuable for translational research in metabolic and neurological diseases.
Metabolomics and flux analysis
Metabolomics involves the comprehensive measurement of small molecules in biological samples using techniques such as mass spectrometry and nuclear magnetic resonance. Flux analysis extends this by tracing the flow of metabolites through pathways using stable isotope-labeled substrates. These methods provide insights into metabolic reprogramming in diseases like cancer and can identify potential therapeutic targets.
How CRISPR Can Be Used to Study GO:0044281 small molecule metabolic process
Knockout
CRISPR knockout (KO) is used to completely ablate the function of a gene involved in small molecule metabolism. By introducing frameshift mutations or deletions, researchers can create cell lines or animal models that lack the gene product. KO models are essential for determining the physiological role of metabolic enzymes and for validating drug targets. For example, KO of LDHA reduces lactate production and impairs tumor growth in xenograft models.
Point Mutation
CRISPR point mutation knock-in allows the introduction of specific single-nucleotide changes into the genome. This is particularly useful for modeling disease-associated mutations in metabolic genes, such as IDH1 R132H, which alters enzyme activity and produces the oncometabolite 2-hydroxyglutarate. Point mutation models help researchers understand how specific amino acid changes affect enzyme kinetics, substrate specificity, and cellular metabolism.
Knock-in
CRISPR knock-in (KI) enables the insertion of larger DNA sequences, such as tags, reporters, or entire genes, at a specific locus. This can be used to create fusion proteins with fluorescent tags (e.g., GFP) or to overexpress a metabolic gene under the control of a native promoter. KI models are valuable for studying protein localization, interactions, and dynamics in the context of small molecule metabolism.
Overexpression
CRISPR overexpression (CRISPRa) uses a catalytically dead Cas9 fused to transcriptional activators to upregulate endogenous gene expression. This approach is useful for studying the effects of increased levels of metabolic enzymes on cellular metabolism and disease. Overexpression models can reveal oncogenic roles of metabolic genes, such as FASN in cancer. They also allow dose-response studies of metabolic pathway flux.
How EDITGENE Supports small molecule metabolic process Research
Researchers studying small molecule metabolic process-related genes often need to determine whether a candidate gene is causally involved in a specific metabolic pathway or disease. This requires precise genetic manipulation, which can be achieved through CRISPR-based models. EDITGENE provides a comprehensive suite of services to support such research, from knockout and point mutation to knock-in and overexpression, as well as library screening and bioinformatics analysis.
Contact EDITGENE today to design your custom CRISPR model for small molecule metabolic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| LRP5 Knockout HEK293 Cell Line | EDJ-KQ313 | Human | 4041 | Details Get a Quote |
| ADH7 Knockout HEK293 Cell Line | EDJ-KQ3532 | Human | 131 | Details Get a Quote |
| CYP27B1 Knockout HEK293 Cell Line | EDJ-KQ3766 | Human | 1594 | Details Get a Quote |
| ADH5 Knockout HEK293 Cell Line | EDJ-KQ4010 | Human | 128 | Details Get a Quote |
| MMUT Knockout HEK293 Cell Line | EDJ-KQ5274 | Human | 4594 | Details Get a Quote |
| DCXR Knockout HEK293 Cell Line | EDJ-KQ10964 | Human | 51181 | Details Get a Quote |
| UPB1 Knockout HEK293 Cell Line | EDJ-KQ11206 | Human | 51733 | Details Get a Quote |
| CTPS2 Knockout HEK293 Cell Line | EDJ-KQ13050 | Human | 56474 | Details Get a Quote |
| L2HGDH Knockout HEK293 Cell Line | EDJ-KQ14021 | Human | 79944 | Details Get a Quote |
| LRP5 Knockout HeLa Cell Line | EDJ-KQ17954 | Human | 4041 | Details Get a Quote |
| ADH5 Knockout A-549 Cell Line | EDJ-KQ24993 | Human | 128 | Details Get a Quote |
| L2HGDH Knockout A-549 Cell Line | EDJ-KQ43926 | Human | 79944 | Details Get a Quote |
| L2HGDH Knockout HCT 116 Cell Line | EDJ-KQ43927 | Human | 79944 | Details Get a Quote |
| L2HGDH Knockout HeLa Cell Line | EDJ-KQ43928 | Human | 79944 | Details Get a Quote |
| LRP5 Knockout A-549 Cell Line | EDJ-KQ18449 | Human | 4041 | Details Get a Quote |
Displaying Records 1 To 15 Of 37 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About small molecule metabolic process
What is small molecule metabolic process (GO:0044281)?
GO:0044281 is a Gene Ontology term that describes the chemical reactions and pathways involving small molecules, which are low-molecular-weight organic compounds. It includes the synthesis, breakdown, and interconversion of metabolites such as sugars, amino acids, and lipids.
What genes are involved in small molecule metabolic process?
Key genes include GAPDH, PKM, LDHA, IDH1, IDH2, SDHA, FH, HK2, PFKM, ALDOA, ENO1, TPI1, PGK1, PGAM1, G6PD, ACLY, FASN, and CPT1A, among many others.
How is small molecule metabolic process regulated?
It is regulated by allosteric effectors, post-translational modifications, hormonal signals (e.g., insulin/glucagon), and transcriptional programs. The mTOR pathway plays a central role in integrating nutrient signals to control metabolism.
Why is small molecule metabolism important in cancer?
Cancer cells reprogram small molecule metabolism to support rapid growth, including increased glycolysis and fatty acid synthesis. Mutations in metabolic enzymes like IDH1 and SDHA can produce oncometabolites that promote tumorigenesis.
What methods are used to study small molecule metabolic process?
Common methods include high-throughput screening, metabolomics, flux analysis, DARTS, organ-on-a-chip, and CRISPR-based gene editing.
How can CRISPR be used to study small molecule metabolism?
CRISPR can create knockout, point mutation, knock-in, and overexpression models to dissect the roles of metabolic genes in cellular pathways and disease.
What diseases are associated with defects in small molecule metabolism?
Diseases include cancer, neurodegenerative disorders like Alzheimer's disease, and inherited metabolic disorders such as triosephosphate isomerase deficiency and G6PD deficiency.
What is the role of small molecules in drug discovery?
Small molecules are the most common class of drugs and can modulate metabolic enzymes, receptors, and signaling proteins. They are also used as tools to probe biological pathways.
How does EDITGENE support research on small molecule metabolic process?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models, as well as CRISPR library screening and bioinformatics services tailored to metabolic genes.
What is the difference between small molecule metabolic process and macromolecule metabolic process?
Small molecule metabolic process deals with low-molecular-weight compounds (e.g., glucose, amino acids), while macromolecule metabolic process involves large polymers like proteins, nucleic acids, and polysaccharides. They are distinct GO terms.
Conclusion
Small molecule metabolic process (GO:0044281) is a fundamental biological process that underpins energy production, biosynthesis, and cellular signaling. Its dysregulation is implicated in a wide range of human diseases, making it a prime target for therapeutic intervention. Advances in CRISPR gene editing, high-throughput screening, and metabolomics have greatly enhanced our ability to study and manipulate small molecule metabolism. EDITGENE offers a comprehensive suite of services to support researchers in this field, from custom cell models to library screening and bioinformatics.
References
- 1. Pai MY et al.. 2015. Drug affinity responsive target stability (DARTS) for small-molecule target identification.. Methods Mol Biol 1263:287-98 PMID: 25618353
- 2. Kawakita S et al.. 2022. Organ-On-A-Chip Models of the Blood-Brain Barrier: Recent Advances and Future Prospects.. Small 18(39):e2201401 PMID: 35978444
- 3. Burslem GM et al.. 2017. Small-Molecule Modulation of Protein Homeostasis.. Chem Rev 117(17):11269-11301 PMID: 28777566
- 4. Kastl JM et al.. 2021. Small-Molecule Degraders beyond PROTACs-Challenges and Opportunities.. SLAS Discov 26(4):524-533 PMID: 33632029
- 6. Rienzo M et al.. 2021. High-throughput screening for high-efficiency small-molecule biosynthesis.. Metab Eng 63:102-125 PMID: 33017684
- 7. Feng Q et al.. 2024. Intranasal Delivery of Pure Nanodrug Loaded Liposomes for Alzheimer's Disease Treatment by Efficiently Regulating Microglial Polarization.. Small 20(50):e2405781 PMID: 39370581
- 8. Banerjee R et al.. 2021. Small-Molecule Tunnels in Metalloenzymes Viewed as Extensions of the Active Site.. Acc Chem Res 54(9):2185-2195 PMID: 33886257
